336 related articles for article (PubMed ID: 34295336)
1. Multi-Omics Analysis Showed the Clinical Value of Gene Signatures of C1QC
Li X; Zhang Q; Chen G; Luo D
Front Immunol; 2021; 12():694801. PubMed ID: 34295336
[TBL] [Abstract][Full Text] [Related]
2. Single-Cell RNA Sequencing Reveals the Heterogeneity of Tumor-Associated Macrophage in Non-Small Cell Lung Cancer and Differences Between Sexes.
Yang Q; Zhang H; Wei T; Lin A; Sun Y; Luo P; Zhang J
Front Immunol; 2021; 12():756722. PubMed ID: 34804043
[TBL] [Abstract][Full Text] [Related]
3. SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration.
Wang C; Li Y; Wang L; Han Y; Gao X; Li T; Liu M; Dai L; Du R
Br J Cancer; 2024 May; 130(11):1770-1782. PubMed ID: 38600327
[TBL] [Abstract][Full Text] [Related]
4. Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation.
Li H; Miao Y; Zhong L; Feng S; Xu Y; Tang L; Wu C; Zhang X; Gu L; Diao H; Wang H; Wen Z; Yang M
Front Immunol; 2023; 14():1162032. PubMed ID: 37187751
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer.
Qiu P; Guo Q; Yao Q; Chen J; Lin J
Front Immunol; 2021; 12():736030. PubMed ID: 34659224
[TBL] [Abstract][Full Text] [Related]
6. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC.
Bao X; Shi R; Zhao T; Wang Y; Anastasov N; Rosemann M; Fang W
Cancer Immunol Immunother; 2021 Jan; 70(1):189-202. PubMed ID: 32681241
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
[TBL] [Abstract][Full Text] [Related]
8. M1
Garrido-Martin EM; Mellows TWP; Clarke J; Ganesan AP; Wood O; Cazaly A; Seumois G; Chee SJ; Alzetani A; King EV; Hedrick CC; Thomas G; Friedmann PS; Ottensmeier CH; Vijayanand P; Sanchez-Elsner T
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32699181
[TBL] [Abstract][Full Text] [Related]
9. The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer.
Xie X; Zhang J; Shi Z; Liu W; Hu X; Qie C; Chen W; Wang Y; Wang L; Jiang J; Liu J
Front Immunol; 2020; 11():563044. PubMed ID: 33250890
[TBL] [Abstract][Full Text] [Related]
10. Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma.
Liu L; Zhang R; Deng J; Dai X; Zhu X; Fu Q; Zhang H; Tong Z; Zhao P; Fang W; Zheng Y; Bao X
Cancer Immunol Immunother; 2022 Jan; 71(1):121-136. PubMed ID: 34028567
[TBL] [Abstract][Full Text] [Related]
11. Integrating single-cell and bulk RNA sequencing reveals CK19 + cancer stem cells and their specific SPP1 + tumor-associated macrophage niche in HBV-related hepatocellular carcinoma.
Yang CL; Song R; Hu JW; Huang JT; Li NN; Ni HH; Li YK; Zhang J; Lu Z; Zhou M; Wang JD; Li MJ; Zhan GH; Peng T; Yu HP; Qi LN; Wang QY; Xiang BD
Hepatol Int; 2024 Feb; 18(1):73-90. PubMed ID: 38159218
[TBL] [Abstract][Full Text] [Related]
12. Integration of single-cell RNA sequencing and bulk RNA transcriptome sequencing reveals a heterogeneous immune landscape and pivotal cell subpopulations associated with colorectal cancer prognosis.
Zhang Q; Liu Y; Wang X; Zhang C; Hou M; Liu Y
Front Immunol; 2023; 14():1184167. PubMed ID: 37675100
[TBL] [Abstract][Full Text] [Related]
13. Potential crosstalk between SPP1 + TAMs and CD8 + exhausted T cells promotes an immunosuppressive environment in gastric metastatic cancer.
Du Y; Lin Y; Gan L; Wang S; Chen S; Li C; Hou S; Hu B; Wang B; Ye Y; Shen Z
J Transl Med; 2024 Feb; 22(1):158. PubMed ID: 38365757
[TBL] [Abstract][Full Text] [Related]
14. IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.
Zeng D; Ye Z; Shen R; Yu G; Wu J; Xiong Y; Zhou R; Qiu W; Huang N; Sun L; Li X; Bin J; Liao Y; Shi M; Liao W
Front Immunol; 2021; 12():687975. PubMed ID: 34276676
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the m6A-Associated Tumor Immune Microenvironment in Prostate Cancer to Aid Immunotherapy.
Liu Z; Zhong J; Zeng J; Duan X; Lu J; Sun X; Liu Q; Liang Y; Lin Z; Zhong W; Wu W; Cai C; Zeng G
Front Immunol; 2021; 12():735170. PubMed ID: 34531875
[TBL] [Abstract][Full Text] [Related]
16. Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer.
Mei J; Xing Y; Lv J; Gu D; Pan J; Zhang Y; Liu J
Int Immunopharmacol; 2020 Nov; 88():106882. PubMed ID: 32799114
[TBL] [Abstract][Full Text] [Related]
17. The role of the hypoxia-Nrp-1 axis in the activation of M2-like tumor-associated macrophages in the tumor microenvironment of cervical cancer.
Chen XJ; Wu S; Yan RM; Fan LS; Yu L; Zhang YM; Wei WF; Zhou CF; Wu XG; Zhong M; Yu YH; Liang L; Wang W
Mol Carcinog; 2019 Mar; 58(3):388-397. PubMed ID: 30362630
[TBL] [Abstract][Full Text] [Related]
18. Novel tumor-associated macrophage populations and subpopulations by single cell RNA sequencing.
Wang J; Zhu N; Su X; Gao Y; Yang R
Front Immunol; 2023; 14():1264774. PubMed ID: 38347955
[TBL] [Abstract][Full Text] [Related]
19. M2 subtype tumor associated macrophages (M2-TAMs) infiltration predicts poor response rate of immune checkpoint inhibitors treatment for prostate cancer.
JiaWei Z; ChunXia D; CunDong L; Yang L; JianKun Y; HaiFeng D; Cheng Y; ZhiPeng H; HongYi W; DeYing L; ZhiJian L; Xiao X; QiZhao Z; KangYi X; WenBing G; Ming X; JunHao Z; JiMing B; ShanChao Z; MingKun C
Ann Med; 2021 Dec; 53(1):730-740. PubMed ID: 34032524
[TBL] [Abstract][Full Text] [Related]
20. Secreted phosphoprotein 1 as a potential prognostic and immunotherapy biomarker in multiple human cancers.
Zeng P; Zhang X; Xiang T; Ling Z; Lin C; Diao H
Bioengineered; 2022 Feb; 13(2):3221-3239. PubMed ID: 35067176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
